May is Bladder Cancer Awareness Month. It serves as a timely reminder to pay attention to subtle signs, especially blood in ...

Notably, treatment usage trends from a Bladder Cancer Advocacy Network (BCAN) survey presented at GU ASCO 2025 revealed that only 1–5% of patients reported having seen a radiation oncologist and only ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

Annual Meeting held in Chicago, IL, was host to a State of the Science session on novel diagnostics and therapeutics in renal cell and urothelial carcinomas. Dr. Wulff-Burchfield discussed strategies ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first ...

More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...

Bladder cancer, a common malignancy, often presents subtle symptoms like blood in urine or painful urination.

Urine for a breakthrough — in a true medical milestone, UCLA surgeons completed the world’s first in-human bladder transplant ...

New treatment combinations are transforming genitourinary cancer care, improving survival and quality of life while ...